Metrion's Senior Leadership Team (SLT) brings together over 125 years of combined drug discovery experience, including 100 years specialising in ion channels. With expertise reflected in approximately 150 scientific publications, our leadership team provides the knowledge and experience that underpin our specialist ion channel screening and drug discovery services.
Drawing on extensive experience across pharmaceutical R&D, biotechnology and CRO operations, our SLT combines scientific expertise with technical and operational leadership to ensure the delivery of high-quality, reliable data that enables our customers to make informed drug discovery decisions.
Lee specialises in steering preclinical CROs to implement robust and effective plans for long-term commercial growth.
Rob is a skilled pharmacologist with over 10 years’ experience in ion channel drug discovery.
Eddy has over 25 years of experience in ion channel drug discovery and is widely published.
Gary has over 25 years of experience in ion channel drug discovery, including more than 20 years in contract research.
Tony has over 25 years of experience in the ion channel field, spanning both academic research and industry and is widely published.
Chris has over 25 years of experience in the biopharmaceutical industry, with a strong background in preclinical CRO leadership, sales and marketing.
Sue is a hands-on marketing leader who manages Metrion's global marketing operations.
Tom brings a deep scientific understanding and analytical approach to his client engagement and strategic development work.
